Table of Contents
International Scholarly Research Notices
Volume 2014 (2014), Article ID 754695, 8 pages
http://dx.doi.org/10.1155/2014/754695
Research Article

Stability Indicating RP-HPLC Method for the Simultaneous Determination of Atorvastatin Calcium, Metformin Hydrochloride, and Glimepiride in Bulk and Combined Tablet Dosage Form

1Government Polytechnic for Women, Gujarathipeta, Srikakulam, Andhra Pradesh 532005, India
2Adept Pharma & Bioscience Excellence Private Limited, 10-3-561/3A/102, Vijayanagar colony, Hyderabad, Andhra Pradesh 500057, India

Received 19 March 2014; Revised 12 July 2014; Accepted 13 July 2014; Published 30 October 2014

Academic Editor: Hugh J. Byrne

Copyright © 2014 Devi Ramesh and Mohammad Habibuddin. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. S. Hermann, “Clinical pharmacology of biguanides,” in Hand Book of Experimental Pharmacology, I. Kulhmann and W. Plus, Eds., pp. 374–407, Springer, Heidelberg, Germany, 1995. View at Google Scholar
  2. Metformin, http://www.drugbank.ca/drugs/DB00331.
  3. Glimepiride, http://www.drugbank.ca/drugs/DB00222.
  4. S. E. Nissen, S. J. Nicholls, K. Wolski et al., “Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial,” JAMA, vol. 299, no. 13, pp. 1561–1573, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. S. N. Davis, “60. Insulin, oral hypoglycemic agents, and the pharmacology of the endocrine pancreas,” in Goodman & Gilman's The Pharmacological Basis of Therapeutics, L. L. Brunton, J. S. Lazo, and K. L. Parker, Eds., p. 1636, McGraw-Hill, New York, NY, USA, 2005. View at Google Scholar
  6. Indian Pharmacoepoea, vol. 2, 2007.
  7. J. M. Malinowski, “Atorvastatin: A hydroxymethylglutaryl-coenzyme A reductase inhibitor,” The American Journal of Health-System Pharmacy, vol. 55, no. 21, pp. 2253–2267, 1998. View at Google Scholar · View at Scopus
  8. C. Harish Kumar Raju, P. Ramalingam, P. V. Vamshi Krishna, N. Ramesh, and B. Sreeram, “Simultaneous determination of metformin hydrochloride, atorvastatin and glimepiride in tablet dosage forms by RP-HPL,” The American Journal of PharmTech Research, vol. 2, no. 4, pp. 991–998, 2012. View at Google Scholar
  9. S. R. Dhaneshwar, J. V. Salunkhe, and V. K. Bhusari, “Validated HPTLC method for simultaneous estimation of metformin hydrochloride, atorvastatin and glimepiride in bulk drug and formulation,” Journal of Analytical and Bioanalytical Techniques, vol. 1, no. 3, pp. 1–5, 2010. View at Google Scholar
  10. P. Srinivasa Rao, P. Nageshwara Rao, G. Ramakrishna, and G. Venkateshwarlu, “Simultaneous determination of Atorvastatin, Metformin and Glimepiride in human plasma by LC-MS/MS and its application to a human pharmacokinetic study,” Journal of Pharmaceutical Analysis, vol. 3, no. 1, pp. 9–19, 2013. View at Google Scholar
  11. D. A. Shah, K. K. Bhatt, M. B. Shankar, R. S. Mehta, T. R. Gandhi, and S. L. Baldania, “RP-HPLC determination of atorvastatin calcium and amlodipine besylate combination in tablets,” Indian Journal of Pharmaceutical Sciences, vol. 68, no. 6, pp. 796–799, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. I. I. Salem, J. Idrees, and J. I. Al Tamimi, “Determination of glimepiride in human plasma by liquid chromatography-electrospray ionization tandem mass spectrometry,” Journal of Chromatography B, vol. 799, no. 1, pp. 103–109, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. F. H. Havaldar and D. L. Vairal, “Simultaneous estimation of glimepiride, rosiglitazone and pioglitazone hydrochloride in the pharmaceutical dosage form,” E-Journal of Chemistry, vol. 7, no. 4, pp. 1326–1333, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Praveenkumar Reddy, D. Boopathy, B. Mathew, M. Prakash, and P. Perumal, “Method development and validation of simultaneous determination of pioglitazone and glimepiride in pharmaceutical dosage form by RP-HPLC,” International Journal of ChemTech Research, vol. 2, no. 1, pp. 50–53, 2010. View at Google Scholar · View at Scopus
  15. K. S. Lakshmi and T. T. Rajesh, “Development and validation of RP-HPLC method for simultaneous determination of glipizide,rosiglitazone, pioglitazone, glibenclamide and glimepiride in pharmaceutical dosage forms andhuman plasma,” Journal of the Iranian Chemical Society, vol. 8, no. 1, pp. 31–37, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Udaykumar Rao and A. Pratima Nikalje, “Determination of Glipizide, Glibenclamide and Glimepiride in a tablet dosage form in the presence of Metformin hydrochloride by Ion pair- reversed phase liquid chromatographic technique,” Journal of Analytical and Bioanalytical Techniques, vol. 1, no. 2, pp. 1–5, 2010. View at Google Scholar
  17. K. S. Lakshmi, T. Rajesh, and S. Sharma, “Simultaneous estimation of metformin and pioglitazone by reversed phase HPLC in pharmaceutical dosage forms,” International Journal Pharmacy and Pharmaceutical Sciences, vol. 1, no. 2, pp. 162–166, 2009. View at Google Scholar
  18. D. Bhavesh, G. Chethan, K. M. Butt, and Shivaprakash, “Estimation of and pharmacokinetics of metformin in human volunteers,” Indian Journal of Pharmaceutical Education and Research, vol. 41, no. 2, pp. 135–139, 2007. View at Google Scholar
  19. H. W. Darwish, S. A. Hassan, M. Y. Salem, and B. A. El-Zeany, “Development and validation of H-point standard addition method applied for the analysis of binary mixture of amlodipine and atorvastatin,” International Journal of Pharma and Bio Sciences, vol. 4, no. 2, pp. P230–P243, 2013. View at Google Scholar · View at Scopus
  20. C. S. N. Malleswararao, M. V. Suryanarayana, and K. Mukkanti, “Simultaneous determination of Sitagliptin phosphate monohydrate and Metformin hydrochloride in tablets by a validated UPLC method,” Scientia Pharmaceutica, vol. 80, no. 1, pp. 139–152, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. ICH and Q2B, “Harmonized tripartite guideline, validation of analytical procedure: methodology, IFPMA,” in Proceedings of the International Conference on Harmonization, 1996.
  22. USP (The United States pharmacopoeia convention) 30-NF 25, Rockville, Md, USA, 1005, 1776, 2007.